Acquired Pelger-Huet anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 26, Issue 11, 2000, Pages 1255-1257

  Gondo, H ^a   Okamura, C ^a   Osaki, K ^a   Shimoda, K ^a   Asano, Y ^a   Okamura, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Fluconazole; Pelger Huet anomaly; Tacrolimus

Indexed keywords

COLCHICINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DNA; FLUCONAZOLE; FLUDARABINE; GLUCOSE; GROWTH FACTOR; HEMOGLOBIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; SULFONAMIDE; TACROLIMUS; TAXOID; THYMOCYTE ANTIBODY; ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DONOR; DRUG INDUCED DISEASE; FATHER; FEMALE; GLUCOSURIA; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEADACHE; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; LEUKOCYTE DISORDER; PRIORITY JOURNAL; THRUSH; BONE MARROW TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION;

ADULT; ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; DRUG INTERACTIONS; FEMALE; FLUCONAZOLE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PELGER-HUET ANOMALY; TACROLIMUS;

EID: 0033625975     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702682     Document Type: Article

References (12)

1. Morphology and classification of the myelodysplastic syndromes and their pathologic variants
2. Reversible pseudo-Pelger anomaly related to sulfisoxazole therapy
3. Association of acquired Pelger-Huet anomaly with taxoid therapy
4. Association of myelodysplastic changes with purine analogues
5. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease
6. Tacrolimus (FK506)
7. Fluconazole therapy in transplant recipients receiving FK506
8. FK506 trough levels in whole blood and plasma in liver transplant recipients
9. Adverse effects of FK506 overdosage after liver transplantation
10. Postoperative glucose metabolism in liver transplant recipients: A two-year prospective randomized study of cyclosporine versus FK506
11. Malignant neoplasms following bone marrow transplantation
12. Malignant tumors occurring after treatment of aplastic anemia